Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man (Q70147809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

R O Böhm

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

K H Rahn

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

541-547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

Direct radioimmunoassay of plasma aldosterone in normal subjects

9 October 2019

cites work

1 reference

12 December 2020

Time Course and Effect of Sodium Intake on Vascular and Hormonal Responses to Enalapril (MK 421) in Normal Subjects

1 reference

12 December 2020

Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition

1 reference

12 December 2020

The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers

1 reference

12 December 2020

Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension

1 reference

12 December 2020

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

12 December 2020

A simple radioassay for angiotensin-converting enzyme

1 reference

12 December 2020

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

1 reference

12 December 2020

The sympathetic nervous system and the renin-angiotensin system in borderline hypertension

1 reference

12 December 2020

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

12 December 2020

Review of the Overall Experience of Captopril in Hypertension

1 reference

12 December 2020

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

12 December 2020

Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension

1 reference

12 December 2020

Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)

1 reference

12 December 2020

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

1 reference

12 December 2020

A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man

1 reference

12 December 2020

Enalapril Worldwide Experience

1 reference

12 December 2020

Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers

1 reference

12 December 2020

Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.

1 reference

12 December 2020

Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00542412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3019702%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference